Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study.
BMC Cancer
; 23(1): 979, 2023 Oct 13.
Article
em En
| MEDLINE
| ID: mdl-37833660
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Gástricas
/
Neutropenia Febril
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article